ClinicalTrials.gg
CompletedNCT04912492Updated Feb 4, 2026

Promoting Prosocial Bystander Behavior in Intoxicated Men: Evaluation of RealConsent2.0

An interventional study of RealConsent1.0 and RealConsent2.0 in Alcohol Intoxication, Sexual Violence and Helping Behavior, sponsored by Georgia State University. Completed at 2 sites in United States. Open to participants aged 21 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-04.

Sponsored by Georgia State University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
667
Allocation
Randomized
Ages
21 Years to 25 Years
Sex
All
01

Study summary

Sexual violence (SV) is a significant public health problem particularly among 18-24 year old populations. A major risk factor for SV is alcohol use, which via its negative impact on cognitive abilities and decision-making acts as a barrier to intervening in situations at-risk for a SV. This study has two main goals: (1) to determine the effects of proximal alcohol use on young (age 21 to 25) men's prosocial bystander behavior in situations considered at-risk for SV, and (2) to determine the efficacy of an evidence-based, web-based program called RealConsent, which has been augmented to include alcohol-specific content within the context of bystander SV ("RealConsent2.0"), on men's prosocial bystander behavior. The primary study endpoint is prosocial bystander behavior and will be assessed via two modes: (1) a virtual reality (VR) environment ("B-SAVE") and (2) a validated self-report measure of bystander behavior that has been modified to include assessment of proximal alcohol use and presence of alcohol within the context.

02

Conditions studied

  • Alcohol Intoxication
  • Sexual Violence
  • Helping Behavior

Browse trials for

03

In context

Alcoholic Intoxication

76 studies on the registry are indexed under Alcoholic Intoxication; 17 are open to participants now.

This study's enrollment of 667 is above the median of 135 across 62 interventional studies indexed under Alcoholic Intoxication.

Browse Alcoholic Intoxication studies →

Lead sponsor

Georgia State University is the lead sponsor of 56 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • identify as a man or transgender man, age (21-25)
  • consume weight-based amount of alcohol at least three times during the past year

Exclusion criteria

Exclusion Criteria:

  • weight over 250 pounds
  • current treatment-seeking for an alcohol use disorder
  • any medical or psychiatric condition, as well as current use of a medication, that would contraindicate alcohol administration.
  • in a relationship over 6 months
  • married/living together
  • Neurological Disorder: diagnosis of a neurological disorder
  • Psychiatric Disorder: past or current diagnosis of bipolar disorder (I or II), schizophrenia, schizoaffective disorder, or any other psychotic disorder
  • Treatment for Alcohol or Drug Use: currently being treated for alcohol, or drug problems; currently interested in seeking treatment for drinking or drug use
  • Physical disability: anh physical disability that would prevent an individual from participating in the virtual reality task (self-report and determined)
  • Significant Hearing Problems: significant hearing problems that would prevent an individual from hearing and responding to the virtual reality task (self-reported and determined)
  • Cardiac Pacemaker
  • Asthma: emergency room visit related to asthma in the past year; use of inhaler more frequently when drinking alcohol; use of oral treatments for asthma in the past year;
  • Legal: any legal restrictions against drinking (e.g., as a condition of probation or parole)
  • Alcohol Abstinence: individuals who consume alcohol monthly or less; individuals who have consumed the amount of alcohol they would be expected to drink during the lab session (determined by their weight) less than 3 times in the last year
  • Head Injury: any past serious head injuries (as indicated by HELPS Brain Injury Screening Tool)
  • Acute Psychiatric Symptomatology: elevated psychological distress as indicated by a score greater than 65 on the Brief Symptom Inventory
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
667 participants (actual)

Study arms

  • Active comparator
    RealConsent 1.0 with Alcohol

    Men assigned to complete a web-based multi-media sexual violence and bystander intervention prevention program. Men assigned to alcohol intoxication arm (target breath alcohol concentration (BrAC=.08).

    Behavioral: RealConsent1.0 · Behavioral: Alcohol intoxication

  • Active comparator
    RealConsent 1.0 with Placebo

    Men assigned to complete a web-based multi-media sexual violence and bystander intervention prevention program. Men assigned to a no-alcohol placebo control arm.

    Behavioral: RealConsent1.0 · Behavioral: No-Alcohol Placebo

  • Experimental
    RealConsent2.0 with Alcohol

    Men assigned to complete a revised web-based multi-media sexual violence and bystander intervention prevention program. Men assigned to alcohol intoxication arm (target BrAC=.08).

    Behavioral: RealConsent2.0 · Behavioral: Alcohol intoxication

  • Experimental
    RealConsent2.0 with Placebo

    Men assigned to complete a revised web-based multi-media sexual violence and bystander intervention prevention program. Men assigned to a no-alcohol placebo control arm.

    Behavioral: RealConsent2.0 · Behavioral: No-Alcohol Placebo

  • Active comparator
    Stress Management with Alcohol

    Men assigned to complete a web-based stress management program. Men assigned to alcohol intoxication arm (target BrAC=.08).

    Behavioral: Stress Management · Behavioral: Alcohol intoxication

  • Active comparator
    Stress Management with Placebo

    Men assigned to complete a web-based stress management program. Men assigned to a no-alcohol placebo control arm.

    Behavioral: Stress Management · Behavioral: No-Alcohol Placebo

Interventions

  • BehavioralRealConsent1.0

    A web-based multi-media sexual violence prevention program that enhances knowledge and skills for effective consent for sex and for prosocial bystander behaviors.

  • BehavioralRealConsent2.0

    A revised and updated web-based multi-media sexual violence prevention program that enhances knowledge and skills for effective consent for sex and for prosocial bystander behaviors, but also integrates new program segments into RealConsent 1.0 specific to how alcohol use can inhibit SV intervention at multiple steps of the decision-making process.

  • BehavioralStress Management

    A web-based multimedia program designed to help individuals recognize the symptoms and sources of stress and provide them with a wide variety of powerful tools for managing stress.

  • BehavioralAlcohol intoxication

    Men assigned to moderate alcohol dose condition (target BrAC .08%) with NIAAA approved alcohol administration procedures

  • BehavioralNo-Alcohol Placebo

    Men assigned to an no-alcohol placebo control condition.

06

What researchers measure

Primary outcomes

  1. Bystander behavior

    Bystander behavior will be assessed by a virtual reality (VR) environment titled, Bystanders in Sexual Assault Virtual Environments (B-SAVE). Participants experience a virtual "house party" and are exposed to 5 situations in which they can either intervene or not. Participants are prompted at two points (with a flashing microphone icon) to verbalize their response in that situation - thus providing 10 opportunities to intervene in sexual risk situations. Verbal responses to each situation are recorded and coded to assess for bystander behavior.

    Time frame: One-month post-intervention

  2. Self-Reported Bystander Behavior

    The 44-item Bystander Behavior Scale involves a description of a scenario in which participants are asked if they were exposed to the scenario, did they engage in the behavior (yes/no), if they had been drinking alcohol (yes/no) and if alcohol was present (yes/ no). Response options range from 0 (no) to 1 (yes) for each of the items. A total score for bystander behavior is calculated ranging from 0 (minimum) to 30 (maximum), with higher scores indicating greater bystander behavior in the last three-months. alcohol (yes/no) and if alcohol was present (yes/ no).

    Time frame: Change from Baseline at 6-months

  3. Self-Reported Bystander Behavior

    The 44-item Bystander Behavior Scale involves a description of a scenario in which participants are asked if they were exposed to the scenario, did they engage in the behavior (yes/no), if they had been drinking alcohol (yes/no) and if alcohol was present (yes/ no). Response options range from 0 (no) to 1 (yes) for each of the items. A total score for bystander behavior is calculated ranging from 0 (minimum) to 30 (maximum), with higher scores indicating greater bystander behavior in the last three-months. alcohol (yes/no) and if alcohol was present (yes/ no).

    Time frame: Change from Baseline at 12-months

Secondary outcomes

  1. Barriers to Sexual Assault Bystander Intervention

    The 16-item Barriers to Sexual Assault Bystander Intervention Scale assess barriers to intervention. Mean scores range from 1 (minimum) to 7 (maximum), with higher scores indicate more barriers to intervention.

    Time frame: Change from Baseline at 6-months

  2. Barriers to Sexual Assault Bystander Intervention

    The 16-item Barriers to Sexual Assault Bystander Intervention Scale assess barriers to intervention. Mean scores range from 1 (minimum) to 7 (maximum), with higher scores indicate more barriers to intervention.

    Time frame: Change from Baseline at 12-months

  3. Outcome Expectancies for Intervening

    The 17-item Outcome Expectancies for Intervening Scale assess outcome expectancies for intervening. Mean scores ranging from 1 (minimum) to 7 (maximum). Higher scores indicate greater positive expectancies for intervening.

    Time frame: Change from Baseline at 6-months

  4. Outcome Expectancies for Intervening

    The 17-item Outcome Expectancies for Intervening Scale assess outcome expectancies for intervening. Mean scores ranging from 1 (minimum) to 7 (maximum). Higher scores indicate greater positive expectancies for intervening.

    Time frame: Change from Baseline at 12-months

  5. Bystander Efficacy Scale

    14-item Bystander Efficacy Scale assess bystander confidence to intervene, with response options ranging from 0 % (minimum) to 100% (maximum). A score is created by subtracting the mean of these 14 items from 100 to create a scale of perceived efficacy. Higher scores indicate greater bystander efficacy.

    Time frame: Change from Baseline at 6-months

  6. Bystander Efficacy Scale

    14-item Bystander Efficacy Scale assess bystander confidence to intervene, with response options ranging from 0 % (minimum) to 100% (maximum). A score is created by subtracting the mean of these 14 items from 100 to create a scale of perceived efficacy. Higher scores indicate greater bystander efficacy.

    Time frame: Change from Baseline at 12-months

  7. Bystander Attitude Scale

    The 12-item Bystander Attitudes Scale assesses bystander intentions. Response options ranging from 1 (minimum) to 5 (maximum), with greater mean scores indicate higher intentions of intervening.

    Time frame: Change from Baseline at 6-months

  8. Bystander Attitude Scale

    The 12-item Bystander Attitudes Scale assesses bystander intentions. Response options ranging from 1 (minimum) to 5 (maximum), with greater mean scores indicate higher intentions of intervening.

    Time frame: Change from Baseline at 12-months

  9. Sexual Violence Perpetration

    The 35 items Sexual Experience Survey will be used to assess sexual violence perpetration. Participants indicate the number of times that they did each act ranging from 0 (never) to 3 (3 or more times), with total scores ranging from 0 to 105 with greater scores indicating more perpetration. The mutually exclusive scoring system will be used. The goal is to count people only once according to the most severe act perpetrated.

    Time frame: Change from Baseline at 6-months

  10. Sexual Violence Perpetration

    The 35 items Sexual Experience Survey will be used to assess sexual violence perpetration. Participants indicate the number of times that they did each act ranging from 0 (never) to 3 (3 or more times), with total scores ranging from 0 to 105 with greater scores indicating more perpetration. The mutually exclusive scoring system will be used. The goal is to count people only once according to the most severe act perpetrated.

    Time frame: Change from Baseline at 12-months

07

Study locations

2 sites
  • Georgia State University
    Atlanta, Georgia 30303, United States
  • University of Nebraska-Lincoln
    Lincoln, Nebraska 68588, United States
08

References and documents

Publications

  • Salazar LF, Parrott DJ, DiLillo D, Gervais S, Schipani-McLaughlin AM, Leone R, Swartout K, Simpson L, Moore R, Wilson T, Flowers N, Church H, Baildon A. Study protocol for a randomized controlled trial of RealConsent2.0: a web-based intervention to promote prosocial alcohol-involved bystander behavior in young men. Trials. 2023 Dec 12;24(1):804. doi: 10.1186/s13063-023-07797-w. PubMed 38087306 ↗

Individual participant data

Plan to share: Yes — After the grant period, access to the data will be provided through the Inter- University Consortium for Political and Social Research (ICPSR). Users will be required to agree to the conditions of use governing access to the public release data, including restrictions against attempting to identify study participants, destruction of the data after analyses are completed, reporting responsibilities, restrictions on redistribution of the data to third parties, and proper acknowledgement of the data source and funders. One year after the study is completed, all data will be compiled and organized into a single repository at ICPSR. Data will be made publicly available through ICPSR's website.

Time frame: One year after the study is completed, all data will be compiled and organized into a single repository at ICPSR.

Access criteria: Users will be required to agree to the conditions of use governing access to the public release data, including restrictions against attempting to identify study participants, destruction of the data after analyses are completed, reporting responsibilities, restrictions on redistribution of the data to third parties, and proper acknowledgment of the data source and funders.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04912492
Lead sponsor
Georgia State University
Collaborators
University of Nebraska Lincoln
Responsible party
Laura F Salazar (Multiple Principal Investigator, Georgia State University) — Principal investigator
First posted
Jun 3, 2021
Start date
Mar 1, 2022
Primary completion
Jul 16, 2025
Completion
Jul 16, 2025
Last update
Feb 4, 2026

Study contacts

Laura Salazar, Ph.D.
principal investigator · Georgia State University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion